熱點掃描 | 百濟神州漲超10%,領漲生物技術板塊
uSMART盈立智投8月5日消息,截止發稿,港股三大指數漲跌不一,恆生指數跌0.2%,報20133.13點,成交額346.46億;國企指數跌0.26%,報6862.99點,成交額111.10億;紅籌指數漲0.15%,報3583.23點,成交額12.92億。
百濟神州漲超10%,領漲生物技術板塊,康方生物漲8.35%,藥明巨諾漲7.21%,再鼎醫藥漲6.5%,泰格醫藥漲4.87%,雲頂新耀漲近4%;
蘋果概念股延續前日漲勢,高偉電子漲1.5%,舜宇光學科技漲1.34%,瑞聲科技漲1.21%,比亞迪電子漲1.14%;
物業服務及管理板塊領漲,旭輝永升服務漲超10%,金科服務、中駿商管漲超8%,新城悅服務漲6.66%,融創服務漲逾5%;
黃金概念股普漲,潼關黃金漲5%、招金礦業漲超4.6%、山東黃金漲近2%、紫金礦業漲1.7%;
石油股普跌,中國海洋石油跌近3%,中國石油股份跌2.3%,中海油田服務跌1%,中國石油化工股跟跌,市場分析稱,油價日內走低主要是由於對美國和歐洲經濟衰退的擔憂,美國能源信息署週三公佈的原油商業庫存超預期增加了446.7萬桶,汽油庫存也意外地增長了16.3萬桶。
熱門股
康希諾生物漲4.1%,報63.5港元;消息面上,康希諾正在上海臨港建設mRNA產業化基地,首期規劃產能爲1億劑,公司提前佈局了可以激發粘膜免疫的吸入劑型的開發,同時也在探索二價疫苗的開發,不僅限於腺病毒載體技術平臺,也在基於mRNA技術平臺進行候選疫苗的開發,公司已開展接種三針滅活疫苗的人羣中序貫加強第四針腺病毒載體新冠疫苗的臨牀試驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.